Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for Atrium Therapeutics, Inc., €65k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Rocio Martin Hoyos: trading record in brief
All filings by Rocio Martin Hoyos on record concern Atrium Therapeutics, Inc. Between 20 April 2026 and 18 September 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 22 September 2026, the filings show a share grant worth €65k in Atrium Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rocio Martin Hoyos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
8,320 shares@ US$8.95Common StockSEC:0001193125-26-397936:0
30,000 shares0Common StockSEC:0001193125-26-170907:0
2 of 2 declarations
